Compare CTS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTS | OMCL |
|---|---|---|
| Founded | 1896 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Computer Manufacturing |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 1994 | 2000 |
| Metric | CTS | OMCL |
|---|---|---|
| Price | $57.85 | $32.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $55.83 |
| AVG Volume (30 Days) | 127.0K | ★ 627.2K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | ★ 15.87 | N/A |
| EPS | 0.59 | ★ 0.77 |
| Revenue | $541,318,000.00 | ★ $787,309,000.00 |
| Revenue This Year | $5.55 | $6.77 |
| Revenue Next Year | $5.00 | $5.22 |
| P/E Ratio | $95.15 | ★ $43.69 |
| Revenue Growth | 4.95 | ★ 9.93 |
| 52 Week Low | $36.03 | $29.06 |
| 52 Week High | $69.55 | $51.84 |
| Indicator | CTS | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 36.91 | 32.27 |
| Support Level | $55.17 | $32.16 |
| Resistance Level | $58.03 | $35.61 |
| Average True Range (ATR) | 1.40 | 1.20 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 32.05 | 0.95 |
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.